![Roche gives lab professionals firsthand glimpse of connected lab of the future at AACC 2016 Clinical Lab Expo Roche gives lab professionals firsthand glimpse of connected lab of the future at AACC 2016 Clinical Lab Expo](https://www.multivu.com/players/English/7889151-roche-aacc-2016/external/cobas-liat-pcr-system-point-of-care-pcr-testing-from-roche-3-HR.jpg)
Roche gives lab professionals firsthand glimpse of connected lab of the future at AACC 2016 Clinical Lab Expo
Quick Reference Instructions cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas®Liat® System For u
![Performance Characteristics of the Roche Diagnostics cobas Liat PCR System as a COVID-19 Screening Tool for Hospital Admissions in a Regional Health Care Delivery System | Journal of Clinical Microbiology Performance Characteristics of the Roche Diagnostics cobas Liat PCR System as a COVID-19 Screening Tool for Hospital Admissions in a Regional Health Care Delivery System | Journal of Clinical Microbiology](https://journals.asm.org/cms/10.1128/JCM.01278-21/asset/2c0e5f18-e67e-4949-b1f7-bc6d1a0d66bd/assets/jcm.01278-21.fp.png)
Performance Characteristics of the Roche Diagnostics cobas Liat PCR System as a COVID-19 Screening Tool for Hospital Admissions in a Regional Health Care Delivery System | Journal of Clinical Microbiology
![FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances - ScienceDirect FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S259013702200053X-gr2.jpg)
FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances - ScienceDirect
cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas Liat System - Healthcare Provider Fact Sheet
![Current state of commercial point-of-care nucleic acid tests for infectious diseases - Analyst (RSC Publishing) DOI:10.1039/D0AN01988G Current state of commercial point-of-care nucleic acid tests for infectious diseases - Analyst (RSC Publishing) DOI:10.1039/D0AN01988G](https://pubs.rsc.org/image/article/2021/AN/d0an01988g/d0an01988g-f2_hi-res.gif)